North East and North Cumbria
ICS Formulary
 
back
4 Central nervous system
04-10-03 Opioid substitution therapy

Buprenorphine Buvidal®
Formulary
  • 8mg/0.16ml 16mg/0.32ml, 24mg/0.48ml, 32mg/0.64ml, 64mg/0.18ml, 96mg/0.27ml, 128mg/0.36ml 160mg/0.45ml prolonged-release solution for injection (pre-filled syringes).
    • Approved for the treatment of opioid dependance  in adults and adolescents aged 16 years and over, by substance misuse service providers, in line with NTAG and RMOC guidance.


 
Link  NTAG - Buprenorphine prolonged release injection for opioid dependence

Controlled Drug  Red View adult BNF  View SPC online  View childrens BNF